Corrigendum to Phase 1b Randomized Controlled Study of Short Course Topical Recombinant Human Nerve Growth Factor (rhNGF) for Neuroenhancement in Glaucoma: Safety, Tolerability, and Efficacy Measure Outcomes. Am J Ophthalmol 2022;234:223-234. [PDF]
Beykin G +15 more
europepmc +1 more source
Public Views on Whether the Use of Pharmaceutical Neuroenhancements Should Be Allowed. [PDF]
Hendriks S, Li X, Grady C, Kim SY.
europepmc +1 more source
Citicoline Triggers Proteome Remodeling and Proteostatic Adaptation: Evidence from Shotgun Proteomics. [PDF]
Cavaterra D +18 more
europepmc +1 more source
Advancements in Neurotechnology: Pioneering Brain Monitoring and Stimulation for Enhanced Treatment and Understanding. [PDF]
Kargbo RB.
europepmc +1 more source
Ethical Governance Strategies for the Responsible Innovation of Neurotechnologies: A Scoping Review. [PDF]
Robertson LJ +4 more
europepmc +1 more source
Advancements in Psychoactive Alkaloid Delivery, Neuroenhancement, and Psychedelic Therapies: Exploring the Frontiers of Modern Pharmacology. [PDF]
Kargbo RB.
europepmc +1 more source
Neuroprotection, Neuroenhancement, and Neuroregeneration of the Retina and Optic Nerve. [PDF]
Johnson TV +3 more
europepmc +1 more source
Chronic alcohol-induced brain states limit propagation of direct cortical stimulation. [PDF]
Habelt B +10 more
europepmc +1 more source
Stimulant abuse as a coping strategy-Forensic and criminal consequences of stimulant abuse for neuroenhancement. [PDF]
Dominik P +3 more
europepmc +1 more source
Why non-invasive brain stimulation should not be used in military and security services
Bernhard eSehm, Patrick eRagert
doaj +1 more source

